Published in Proc Natl Acad Sci U S A on December 19, 2016
Astrocytes fuel the fire of lymphocyte toxicity after stroke. Proc Natl Acad Sci U S A (2017) 0.75
Distinctive Roles for α7*- and α9*-Nicotinic Acetylcholine Receptors in Inflammatory and Autoimmune Responses in the Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis. Front Cell Neurosci (2017) 0.75
A translocator protein 18 kDa agonist protects against cerebral ischemia/reperfusion injury. J Neuroinflammation (2017) 0.75
Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol (2010) 27.58
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 22.34
Hypoxia and inflammation. N Engl J Med (2011) 7.71
Ischemia and reperfusion--from mechanism to translation. Nat Med (2011) 6.64
Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke (2001) 6.61
The immunology of stroke: from mechanisms to translation. Nat Med (2011) 6.53
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat Rev Immunol (2006) 6.22
IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity (2002) 6.10
CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology (2000) 5.63
Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity (2007) 5.50
Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature (2010) 5.24
Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol (2006) 4.98
Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation (2006) 4.61
Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat Med (1997) 4.03
NK cell development, homeostasis and function: parallels with CD8⁺ T cells. Nat Rev Immunol (2011) 3.38
Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol (2013) 3.38
IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med (2008) 3.03
The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med (1996) 2.99
GFAP promoter directs astrocyte-specific expression in transgenic mice. J Neurosci (1994) 2.77
Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci U S A (2004) 2.66
Brain-immune communication pathways. Brain Behav Immun (2007) 2.50
A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry (2005) 2.41
A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J Neurosci Methods (2002) 2.35
IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev (2006) 2.29
Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood (2010) 2.17
The blood-brain barrier and immune function and dysfunction. Neurobiol Dis (2009) 2.08
Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab (2000) 2.06
The immunology of acute stroke. Nat Rev Neurol (2012) 2.06
The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J (2006) 2.04
Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse. Exp Neurol (2006) 1.86
A subset of natural killer cells is greatly expanded within inflamed joints. Arthritis Rheum (2002) 1.71
Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J Exp Med (2010) 1.70
GFAP promoter elements required for region-specific and astrocyte-specific expression. Glia (2008) 1.65
Trans-presentation: a novel mechanism regulating IL-15 delivery and responses. Immunol Lett (2009) 1.64
Functional assessments in the rodent stroke model. Exp Transl Stroke Med (2010) 1.61
Changes in experimental stroke outcome across the life span. J Cereb Blood Flow Metab (2009) 1.58
Astrocyte barriers to neurotoxic inflammation. Nat Rev Neurosci (2015) 1.53
Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation. Nat Neurosci (2016) 1.48
Organ-specific features of natural killer cells. Nat Rev Immunol (2011) 1.48
Ischemic postconditioning inhibits apoptosis after focal cerebral ischemia/reperfusion injury in the rat. Stroke (2008) 1.47
The voltage-gated proton channel Hv1 enhances brain damage from ischemic stroke. Nat Neurosci (2012) 1.45
Microglial responses after ischemic stroke and intracerebral hemorrhage. Clin Dev Immunol (2013) 1.43
Interleukin-15: a new cytokine target for the treatment of inflammatory diseases. Curr Opin Pharmacol (2004) 1.41
Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat Immunol (2000) 1.40
Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation. Blood (2008) 1.39
Brain-immune interactions and ischemic stroke: clinical implications. Arch Neurol (2012) 1.34
Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis. J Immunol (2004) 1.33
Microglia and ischemic stroke: a double-edged sword. Int J Physiol Pathophysiol Pharmacol (2013) 1.33
IL-15 induces the expression of chemokines and their receptors in T lymphocytes. J Immunol (1999) 1.32
Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity. J Neurosci (1995) 1.28
Limitations to oxygen diffusion and equilibration in in vitro cell exposure systems in hyperoxia and hypoxia. Am J Physiol Lung Cell Mol Physiol (2001) 1.27
Na-K-Cl cotransporter-mediated intracellular Na+ accumulation affects Ca2+ signaling in astrocytes in an in vitro ischemic model. J Neurosci (2004) 1.25
Ischemic neurons recruit natural killer cells that accelerate brain infarction. Proc Natl Acad Sci U S A (2014) 1.16
Attenuated inflammatory response in aged mice brains following stroke. PLoS One (2011) 1.14
IL-15 transpresentation promotes both human T-cell reconstitution and T-cell-dependent antibody responses in vivo. Proc Natl Acad Sci U S A (2011) 1.10
IL-15 transpresentation augments CD8+ T cell activation and is required for optimal recall responses by central memory CD8+ T cells. J Immunol (2008) 1.10
Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease. Gastroenterology (1998) 1.08
Interleukin-15 gene expression in human astrocytes and microglia in culture. Neuroreport (1996) 1.07
Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis. J Immunol (2010) 1.07
CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke. J Neuroinflammation (2014) 0.99
Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke. Prog Neurobiol (2015) 0.99
Rat focal cerebral ischemia induced astrocyte proliferation and delayed neuronal death are attenuated by cyclin-dependent kinase inhibition. J Clin Neurosci (2008) 0.98
Interleukin 15 expression in the CNS: blockade of its activity prevents glial activation after an inflammatory injury. Glia (2008) 0.98
Different NK cell developmental events require different levels of IL-15 trans-presentation. J Immunol (2011) 0.98
Concurrent assessment of calpain and caspase-3 activation after oxygen-glucose deprivation in primary septo-hippocampal cultures. J Cereb Blood Flow Metab (2001) 0.97
Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats. Neuroscience (2006) 0.93
Increased chemokine gene expression during aging in the murine brain. Brain Res (2001) 0.92
alpha-Melanocyte-stimulating hormone is neuroprotective in rat global cerebral ischemia. Neuropeptides (2006) 0.91
Interleukin-15 and interferon-gamma participate in the cross-talk between natural killer and monocytic cells required for tumour necrosis factor production. Arthritis Res Ther (2006) 0.89
Mouse models of neurological disorders: a view from the blood-brain barrier. Biochim Biophys Acta (2009) 0.88
Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke. Nat Commun (2016) 0.87
Non-pharmaceutical therapies for stroke: mechanisms and clinical implications. Prog Neurobiol (2014) 0.86
Age- and location-related changes in microglial function. Neurobiol Aging (2015) 0.86
Local communication among mucosal immune cells in patients with celiac disease. Gastroenterology (2015) 0.85
Globin-coupled heme containing oxygen sensor soluble adenylate cyclase in Leishmania prevents cell death during hypoxia. Proc Natl Acad Sci U S A (2013) 0.85
Accumulation of natural killer cells in ischemic brain tissues and the chemotactic effect of IP-10. J Neuroinflammation (2014) 0.83
IL-15 amplifies the pathogenic properties of CD4+CD28- T cells in multiple sclerosis. J Immunol (2015) 0.82
Cilostazol, a phosphodiesterase 3 inhibitor, protects mice against acute and late ischemic brain injuries. Eur J Pharmacol (2006) 0.82
Age-Associated Resident Memory CD8 T Cells in the Central Nervous System Are Primed To Potentiate Inflammation after Ischemic Brain Injury. J Immunol (2016) 0.82
T Cell Recruitment in the Brain during Normal Aging. Front Cell Neurosci (2012) 0.81
Colony stimulating factor 1 receptor inhibition eliminates microglia and attenuates brain injury after intracerebral hemorrhage. J Cereb Blood Flow Metab (2016) 0.79
Rituximab-induced interleukin-15 reduction associated with clinical improvement in rheumatoid arthritis. Immunology (2014) 0.78
Antigen dependently activated cluster of differentiation 8-positive T cells cause perforin-mediated neurotoxicity in experimental stroke. J Neurosci (2014) 0.78
Skeletal muscle interleukin 15 promotes CD8(+) T-cell function and autoimmune myositis. Skelet Muscle (2015) 0.76
Lack of association between IL-15 genetic variants and progression of joint destruction in Japanese patients with rheumatoid arthritis. Ann Rheum Dis (2013) 0.76
Augmentation of Circulating Follicular Helper T Cells and Their Impact on Autoreactive B Cells in Myasthenia Gravis. J Immunol (2016) 0.77
CFHR1-Modified Neural Stem Cells Ameliorated Brain Injury in a Mouse Model of Neuromyelitis Optica Spectrum Disorders. J Immunol (2016) 0.75
Acetylcholine-producing NK cells attenuate CNS inflammation via modulation of infiltrating monocytes/macrophages. Proc Natl Acad Sci U S A (2017) 0.75